Moderna (NASDAQ:MRNA) was among the notable gainers on Wednesday after Oracle (NYSE:ORCL) Chairman Larry Ellison highlighted the AI's potential in the development of messenger RNA-based cancer ...

Oracle chairman Larry Ellison has announced that AI will soon develop customised mRNA vaccine against cancer for every individual within 48 hours.

Moderna (MRNA) stock gained after Oracle (ORCL) Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.

Stargate AI project could help create cancer mRNA vaccine, Oracle CEO Larry Ellison says President Donald Trump says project will create more than 100,000 American jobs Prev Next ...

Oracle Chairman Larry Ellison highlighted the potential medical benefits of the investment, stating that AI could be used to detect cancers and customize mRNA vaccines to treat them within 48 hours.

Oracle’s Larry Ellison on AI cancer detection game-changer. ... "And you can make that vaccine, that mRNA vaccine, you can make that robotically again using AI in about 48 hours." ...

Shares of Moderna (MRNA-2.49%) zoomed as much as 33.3% higher this week, according to data from S&P Global Market Intelligence.. The maker of vaccines, including the mRNA vaccine for COVID-19, is ...

Legislation aimed to ban or limit mRNA vaccines was introduced this ... Patients would undergo blood tests and AI would be ... and have that vaccine available in 48 hours," Oracle co-founder ...

Of course, anti-vaxxers have been known to falsely claim that vaccines made with messenger RNA (mRNA) for Covid-19 are in fact harmful to the people who receive them, and even cause cancers. On X ...

Oracle Chairman Larry Ellison said that artificial intelligence (AI) can detect cancer, help develop a vaccine as well as in 48 hours make that vaccine available for every individual person.

March 14, 2025 MRNA vaccines, once a Trump boast, now face attacks from some in GOP The cutting-edge technology used in COVID-19 shots may lead to new treatments for other diseases.

While many people hadn’t heard of the mRNA platform until the covid shots were rolled out, it was discovered in the 1960s. The first mRNA flu vaccines were tested in mice in the 1990s.